Compositions for a dietary supplement to manage senescent cells
US-2024390346-A1 · Nov 28, 2024 · US
US10149877B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10149877-B2 |
| Application number | US-201615296533-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 18, 2016 |
| Priority date | Sep 16, 2011 |
| Publication date | Dec 11, 2018 |
| Grant date | Dec 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to combinations of an agent that stimulates cell proliferation and an anti-inflammatory/analgesic, which are useful in the treatment of peripheral ulcers of various origins, such as radiation dermatitis, diabetic ulcers, ulcers caused by venous stasis of the limbs, bedsores, and the associated skin infections, proctitis, vulvovaginitis and haemorrhoids with vascular lesions. These combinations can be presented as formulations for topical use.
Opening claim text (preview).
The invention claimed is: 1. A composition comprising: a) bisulphite adducts of anthocyanosides from Vaccinium myrtillus, b) a lipophilic extract of Echinacea sp, wherein the composition contains 0.05 to 2% of said bisulphite adducts and 0.01 to 1% of said lipophilic extract of Echinacea sp. 2. The composition according to claim 1 , wherein the lipophilic extract of Echinacea sp. is a lipophilic extract of Echinacea angustifolia or Echinacea purpurea. 3. The composition according to claim 1 suitable for topical administration. 4. A composition comprising a) bisulphite adducts of anthocyanosides from Vaccinium myrtillus, b) anthocyanosides from Vaccinium myrtillus ; and c) a lipophilic extract of Echinacea sp, wherein the composition contains 0.05 to 2% of said bisulphite adducts and 0.01 to 1% of said lipophilic extract of Echinacea sp. 5. The composition according to claim 4 , wherein the extract of Echinacea sp. is a lipophilic extract of Echinacea angustifolia or Echinacea purpurea. 6. The composition according to claim 4 suitable for topical administration.
Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
Local antiseptics · CPC title
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.